ATLASIN8bio (INAB) earnings date: Nov 5, 2026
IN8bio (INAB) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026. Analysts expect EPS of -$0.57.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on INAB
| Last price | $0.96 (+6.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.2% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
These figures come from the same calibrated model and valuation as the IN8bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
IN8bio reports on Nov 5, 2026. One email the day before, with ATLAS’s read on IN8bio. You can switch it off at any time.
Alert me before INAB reportsFree to start. Creating an account takes under a minute.
Notify me when IN8bio reports
Track INAB free Add IN8bio to a free ATLAS watchlist and see its next report date in one place.
INAB earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.57 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +20.3% |
| Average move around a report | ±2.6% (last 4) |
| Sector | Healthcare · Biotechnology |
IN8bio earnings history: last 4 reports
IN8bio last reported on Aug 6, 2026: EPS of -$0.25 against an estimate of -$0.37 (+32.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.37 | -$0.25 | +32.4% | Beat | -1.0% |
| May 5, 2026 | $2.88 | $3.30 | +14.6% | Beat | -1.9% |
| Mar 12, 2026 | -$0.47 | -$0.45 | +4.3% | Beat | -5.0% |
| Feb 26, 2026 | $0.20 | $0.26 | +30.0% | Beat | +2.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for INAB
See the fair value, the probability range and the earnings history of IN8bio on its ATLAS page.
IN8bio (INAB) stock analysisPlans from €3.99 a month.
IN8bio earnings: frequently asked questions
When does IN8bio (INAB) report earnings?
IN8bio is scheduled to report on Thursday, November 5, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for INAB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.57 per share (USD). Estimates can change before the report.
How often does INAB beat earnings estimates?
Of its last 4 reports with a recorded result, IN8bio beat the EPS estimate 4 times; the average surprise was +20.3%. Past results do not predict the next one.
How much does INAB move around earnings?
Over its last 4 reports the stock moved an average of 2.6% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did IN8bio beat earnings estimates last quarter?
IN8bio last reported on Aug 6, 2026: EPS of -$0.25 against an estimate of -$0.37 (+32.4% surprise), a beat.
How much does INAB usually move in a day?
On a normal trading day the ATLAS model puts INAB’s one-day range at about ±5.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer